AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27155753
Drug: SFC group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SFC group (25/50 μg b.i.d.)
Trial: 29960692
Drug: Pill placebo
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill placebo
Trial: 8986681
Drug: 2.5 mg/d
RxNorm normalized name: Androderm 2.5 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/d tibolone (n = 15)
Trial: 11379362
Drug: Eradication treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication treatment (pantoprazole 40 mg once daily, amoxycillin 100 mg b.i.d., clarithromycine 500 mg b.i.d.)
Trial: 30522667
Drug: RESOLUTE Integrity
RxNorm normalized name: Motegrity
DrugBank: Prucalopride (DB06480)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: RESOLUTE Integrity drug-eluting stent (DES)
Trial: 11751775
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (CI) of ceftazidime
Trial: 8569363
Drug: Horse-chestnut seed
RxNorm normalized name: horse chestnut seed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Horse-chestnut seed extract (HCSE, 50 mg aescin, twice daily)
Trial: 1722443
Drug: Islet amyloid
RxNorm normalized name: Islet amyloid polypeptide
DrugBank: Amlintide (DB16614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Islet amyloid polypeptide infusion (150 pmol min‐1 kg‐1)
Trial: 30823945
Drug: Liraglutide combined
RxNorm normalized name: Liraglutide
DrugBank: Liraglutide (DB06655)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Liraglutide combined with insulin
Trial: 25302456
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL 1% lignocaine PPNB and 100 mg diclofenac suppository
Trial: 17244282
Drug: Mitomycin-C (MMC)
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin-C (MMC) 40 mg
Trial: 29289702
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of financial incentives for dietary self-monitoring and interim weight loss
Trial: 17244282
Drug: Bacillus Calmette-Guérin
RxNorm normalized name: Bacillus Calmette-Guérin (BCG) vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus Calmette-Guérin (BCG) 120 mg
Trial: 30682452
Drug: Azithromycin (AZM)
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin (AZM) treatment
Trial: 7517829
Drug: Intensive drug
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive drug treatment (in men)
Trial: 31348349
Drug: Hand therapy
RxNorm normalized name: Octinoxate 3.00 mL in 75 mL / Avobenzone 1.5 mL in 75 mL TOPICAL CREAM [Botanics Daily Hand Therapy Sunscreen SPF 10]
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand therapy (shorter duration)
Trial: 25702958
Drug: Usual protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual protein intake (UP, <1.2 g of protein/kg body weight/d)
Trial: 20439572
Drug: Herpes zoster
RxNorm normalized name: ZOSTER VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herpes zoster vaccine
Trial: 9578931
Drug: Combined ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined ipratropium bromide (0.06% two sprays per nostril) and oxymetazoline (0.05% two sprays per nostril)
Trial: 24090124
Drug: Teflon infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Teflon infusion set
Trial: 17684125
Drug: Regular ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Regular ibuprofen users homozygous for the variant allele at either M9V or D175G
Trial: 19842721
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (2000-U bolus + 500 U/h)
Trial: 22879314
Drug: basic fibroblast
RxNorm normalized name: Basic Fibroblast Growth Factor
DrugBank: Basic Fibroblast Growth Factor (DB14131)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: basic fibroblast growth factor (bFGF) treatment
Trial: 25424454
Drug: 3 h
RxNorm normalized name: Type 3 H
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 h 100 g OGTT using the Carpenter‐Coustan criteria
Trial: 25424454
Drug: 2 h
RxNorm normalized name: Type 2 H
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 h 75 g OGTT or whichever test is recommended by their doctor
Trial: 16022966
Drug: Metyrapone 750
RxNorm normalized name: Metyrapone
DrugBank: Metyrapone (DB01011)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metyrapone 750 mg x 2
Trial: 25125441
Drug: Sham electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham electrical stimulation combined with repetitive task practice therapy
Trial: 26727697
Drug: Tonsillectomy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tonsillectomy combined with drug therapy (Group A)
Trial: 19834016
Drug: Loose control
RxNorm normalized name: Goose
DrugBank: Goose (DB10874)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loose control (target 70 to 200 mg/dL)
Trial: 105622
Drug: Type B
RxNorm normalized name: HLA type B IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type B vitamin combination (5 mg/day thiamin HCl and 3 mg/day pyridoxine HCl)
Trial: 105622
Drug: Type C
RxNorm normalized name: HLA type C IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type C vitamin combination (5 mg/day thiamin HCl and 3 mg/day pyridoxine HCl)
Trial: 105622
Drug: Type A
RxNorm normalized name: HLA type A IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type A vitamin combination (55 mg/day thiamin HCl and 102 mg/day pyridoxine HCl)
Trial: 15610940
Drug: Immediate-release (IR)
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release (IR) isradipine 15 mg
Trial: 20051377
Drug: Sulindac 150
RxNorm normalized name: sulindac 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac 150 mg twice daily for 6 weeks
Trial: 12067330
Drug: IgG anti-GM1
RxNorm normalized name: anti-CD11a
DrugBank: Efalizumab (DB00095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IgG anti-GM1 antibodies in normal controls (detection via ELISA, initial dilution 1:200, positive at absorbance > 0.1)
Trial: 2303582
Drug: ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen 800 mg aqueous suspension
Trial: 2303582
Drug: ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen 800 mg orange juice suspension
Trial: 8122728
Drug: Weekly donation
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly donation intervals (group II)
Trial: 10806602
Drug: Sibrafiban with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibrafiban with heparin
Trial: 6689389
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) 20 mg
Trial: 30836981
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of renin-angiotensin system inhibitors (RASi)
Trial: 4140268
Drug: Atropine injection
RxNorm normalized name: atropine Injection
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine injection
Trial: 30501824
Drug: Dexamethasone administration
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone administration to women before elective cesarean section (group 1)
Trial: 15846191
Drug: Brief folic
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief folic acid counseling, a reminder phone call, and 30 folic acid tablets (n = 162 women)
Trial: 30317548
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (20,000 IU weekly)
Trial: 12092646
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (75 mg intramuscularly)
Trial: 15370723
Drug: Etoricoxib 60
RxNorm normalized name: etoricoxib 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib 60 mg
Trial: 8769362
Drug: Combined GH
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined GH and T3 administration
Trial: 9125680
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside (1, 2, and 4 microg/100 ml forearm tissue/min)
Trial: 820813
Drug: Antibiotic usage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic usage
Trial: 25278342
Drug: Self-control strength
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-control strength training (maximal endurance contractions of spring handgrip trainers, twice daily)
Trial: 9006561
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy after BCS in Ontario
Trial: 12472985
Drug: Haloperidol 20
RxNorm normalized name: haloperidol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 20 mg/day plus Diazoxide 200 mg/day
Trial: 12472985
Drug: Haloperidol 20
RxNorm normalized name: haloperidol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 20 mg/day plus Placebo
Trial: 22368281
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg
Trial: 18997143
Drug: White patients
RxNorm normalized name: White Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White patients not filling prescription medications
Trial: 24660604
Drug: Reduning injection
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduning injection (Group B)
Trial: 11450868
Drug: Amoxicillin 3
RxNorm normalized name: amoxicillin 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 3 g and clavulanic acid 750 mg, 1 dose daily for 2 days
Trial: 29365351
Drug: icosapent ethyl
RxNorm normalized name: Icosapent Ethyl
DrugBank: Icosapent ethyl (DB08887)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: icosapent ethyl 4 g/d
Trial: 9468240
Drug: 6 MU
RxNorm normalized name: Pancrelipase 16 mu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 MU of interferon daily for 4 weeks followed by 6 MU three times weekly for 18 weeks (total dose, 660 MU)
Trial: 2012351
Drug: 10 days
RxNorm normalized name: AlleRx 10-day Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 days of therapy with trimethoprim-sulfamethoxazole (160-800 mg twice daily)
Trial: 18979160
Drug: 800 IU
RxNorm normalized name: Vitamin E 800 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 IU daily cholecalciferol
Trial: 12773957
Drug: Oral ethinyl
RxNorm normalized name: ethinyl estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ethinyl oestradiol
Trial: 7808029
Drug: ATRA and
RxNorm normalized name: ATRA
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ATRA and intensive chemotherapy
Trial: 17021318
Drug: Sham injections
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham injections
Trial: 25925891
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of sipuleucel-T with AA + P
Trial: 14762867
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) at a dose of 10mg/kg/h
Trial: 14762867
Drug: Aprotinin (AP)
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprotinin (AP) with a loading dose of 2 x 10(6) KIU followed by an infusion of 500,000 KIU/h
Trial: 10094218
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (500 microg twice daily) via Diskus
Trial: 19231633
Drug: A-002 (1-H-indole-3-glyoxamide)
RxNorm normalized name: heparinoids 0.002 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A-002 (1-H-indole-3-glyoxamide) 500 mg twice daily
Trial: 9119355
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (radiotherapy followed by melphalan and prednisone every 6 weeks for 3 years)
Trial: 27037462
Drug: Short-interval misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-interval misoprostol (2 placebo tablets at 12 hours and 2 tablets of 400 μg at 3 hours before procedure)
Trial: 22609108
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m(2) and nedaplatin 80 mg/m(2) intravenously on day 1 every 28 days
Trial: 31815770
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion nanotechnology monitoring system with fuzzy logic alarm algorithm
Trial: 24805894
Drug: Cognitive Symptom
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Symptom Management and Rehabilitation Therapy (CogSMART)
Trial: 30056389
Drug: Routine aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine aspirin 75 mg from 11 until 36 weeks
Trial: 26593941
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of C. forskohlii extract, twice daily for 12 weeks
Trial: 8777828
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (as required)
Trial: 30114246
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of glargine (1.6 U/kg body weight)
Trial: 31058615
Drug: Negative control
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative control - no bleaching treatment
Trial: 21557207
Drug: Sivelestat sodium
RxNorm normalized name: Sivelestat
DrugBank: Sivelestat (DB12863)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Sivelestat sodium hydrate (SSH) administered intravenously for 7 days
Trial: 348379
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA), 750 mg 4 times daily
Trial: 30937940
Drug: Flibanserin 100
RxNorm normalized name: flibanserin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flibanserin 100 mg oral dose
Trial: 30401602
Drug: Preoperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative oral carbohydrate solution (OCS) administration
Trial: 31538430
Drug: Short-term exposure
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term exposure to PM2.5 exceeding 50 µg/m3
Trial: 31538430
Drug: Very short-term
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Very short-term exposure to PM2.5 exceeding 50 µg/m3 for 2 hours
Trial: 30507875
Drug: Acemetacin (5 mg/kg/d)
RxNorm normalized name: acemetacin
DrugBank: Acemetacin (DB13783)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acemetacin (5 mg/kg/d)
Trial: 26765317
Drug: High analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High analgesic consumption
Trial: 30499511
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection of ranibizumab, 0.05 ml, administered twice with one-month interval.
Trial: 27442000
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of betamethasone and lidocaine into the lumbar facet joint
Trial: 2287055
Drug: Conventional cefaclor
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional cefaclor preparation (CCL) (500 mg three times daily for 5 days)
Trial: 18083783
Drug: Human Insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human Insulin
Trial: 14500805
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Parathyroid hormone + Alendronate)
Trial: 6140541
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid 2 g orally in divided doses
Trial: 8872689
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rocuronium 0.6 mg/kg and mivacurium 0.15 mg/kg
Trial: 6472796
Drug: Solcoseryl Eye-Gel
RxNorm normalized name: Solcoseryl
DrugBank: Solcoseryl (DB15794)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solcoseryl Eye-Gel
Trial: 6365147
Drug: PUVA and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUVA and etretinate (0.75 mg/kg)
Trial: 15631537
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 20 mg/day
Trial: 31119456
Drug: No insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No insulin (control)
Trial: 2705633
Drug: Gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 600 mg daily
Trial: 20673678
Drug: BNP-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BNP-guided therapy
Trial: 1098495
Drug: Oral rifampin
RxNorm normalized name: Rifampin
DrugBank: Rifampin (DB01045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rifampin (600 mg daily)
Trial: 29771066
Drug: Intratympanic budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intratympanic budesonide injection
Trial: 19342396
Drug: Dexamethasone 0.25
RxNorm normalized name: dexamethasone 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.25 mg daily
Trial: 2576322
Drug: Neuroleptic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic treatment
Trial: 29343131
Drug: Plecanatide 3
RxNorm normalized name: plecanatide 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plecanatide 3 mg
Trial: 26315980
Drug: Second-generation antipsychotic
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antipsychotic treatment
Trial: 29545635
Drug: Plecanatide 3
RxNorm normalized name: plecanatide 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plecanatide 3 mg and 6 mg
Trial: 19094430
Drug: Thiamine pyrophosphate
RxNorm normalized name: Thiamine pyrophosphate
DrugBank: Cocarboxylase (DB01987)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiamine pyrophosphate (TPP) 1 mg/kg
Trial: 31606460
Drug: Pooled human
RxNorm normalized name: Coagulation Factor X (Pooled Human Plasma)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pooled human immune globulin-eye drops (IVIG 4 mg/mL) twice a day for 8 weeks
Trial: 28770947
Drug: Single-agent or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent or combination anti-epileptic therapy with oxcarbazepine and sodium valproate
Trial: 3908603
Drug: Povidone iodine
RxNorm normalized name: POVIDONE IODINE
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone iodine treatment before suture